Controlling destiny through chemistry: Small-molecule regulators of cell fate

ACS Chemical Biology

Volumn 5, Issue 1, 2010, Pages 15-34

  Firestone, Ari J ^a   Chen, James K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; ANTINEOPLASTIC AGENT; AZACITIDINE; BETA CATENIN; CYCLOPAMINE; GDC 0449; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INDOLACTAM V; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; SORAFENIB; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR GLI3; UNCLASSIFIED DRUG; VALPROIC ACID;

BASAL CELL CARCINOMA; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; COLORECTAL CANCER; DRUG EFFICACY; DRUG INHIBITION; EMBRYO DEVELOPMENT; ENDOMETRIUM CARCINOMA; GENE EXPRESSION; GENE TARGETING; GENOME; HEMATOPOIESIS; HOLOPROSENCEPHALY; HUMAN; HYPOGONADISM; LIVER CELL CARCINOMA; LUNG SMALL CELL CANCER; MEDULLOBLASTOMA; MELANOMA; MULTIPLE MYELOMA; NONHUMAN; ONTOGENY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SOMATIC CELL; UBIQUITINATION; UTERINE CERVIX CARCINOMA;

CELL DIFFERENTIATION; HUMANS; REGENERATIVE MEDICINE; SMALL MOLECULE LIBRARIES;

EID: 75749099851     PISSN: 15548929     EISSN: None     Source Type: Journal    
DOI: 10.1021/cb900249y     Document Type: Review

References (138)

1. Vickaryous, M. K., and Hall, B. K. (2006) Human cell type diversity, evolution, development, and classification with special reference to cells derived from the neural crest, Biol. Rev. Cambridge Philos. Soc. 81, 425-455.
2. Jiang, J., and Hui, C.-c. (2008) Hedgehog signaling in development and cancer, Dev. Cell 15, 801-812.
3. Macdonald, B. T., Tamai, K., and He, X. (2009) Wnt/β-catenin signaling: components, mechanisms, and diseases, Dev. Cell 17, 9-26.
4. Wu, M. Y., and Hill, C. S. (2009) Tgf-β superfamily signaling in embryonic development and homeostasis, Dev. Cell 16, 329-343.
5. Beenken, A., and Mohammadi, M. (2009) The FGF family: biology, pathophysiology and therapy, Nat. Rev. Drug Discovery 8, 235-253.
6. Bolós, V., Grego-Bessa, J., and de la Pompa, J. L. (2007) Notch signaling in Development and cancer, Endocr. Rev. 28, 339-363.
7. Massagué, J. (2008) TGFβ in cancer, Cell 134, 215-230.
8. Schugar, R. C., Robbins, P. D., and Deasy, B. M. (2008) Small molecules in stem cell self-renewal and differentiation, Gene Ther. 15, 126-135.
9. Xu, Y., Shi, Y., and Ding, S. (2008) A chemical approach to stemcell biology and regenerative medicine, Nature 453, 338-344.
10. Wechsler-Reya, R. J., and Scott, M. P. (1999) Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog, Neuron 22, 103-114.
11. Levy, V., Lindon, C., Harfe, B. D., and Morgan, B. A. (2005) Distinct stem cell populations regenerate the follicle and interfollicular epidermis, Dev. Cell 9, 855-861.
12. Roelink, H., Augsburger, A., Heemskerk, J., Korzh, V., Norlin, S., Ruiz i Altaba, A., Tanabe, Y., Placzek, M., Edlund, T., and Jessell, T. M., et al. (1994) Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord, Cell 76, 761-775.
13. Litingtung, Y., Dahn, R. D., Li, Y., Fallon, J. F., and Chiang, C. (2002) Shh and Gli3 are dispensable for limb skeleton formation but regulate digit number and identity, Nature 418, 979-983.
14. Neumann, C. J., and Nuesslein-Volhard, C. (2000) Patterning of the zebrafish retina by a wave of sonic hedgehog activity, Science 289, 2137-2139.
15. Canto, P., Soderlund, D., Reyes, E., and Mendez, J. P. (2004) Mutations in the desert hedgehog (DHH) gene in patients with 46, XY complete pure gonadal dysgenesis, J. Clin. Endocrinol. Metab. 89, 4480-4483.
16. Belloni, E., Muenke, M., Roessler, E., Traverso, G., Siegel-Bartelt, J., Frumkin, A., Mitchell, H. F., Donis-Keller, H., Helms, C., Hing, A. V., Heng, H. H., Koop, B., Martindale, D., Rommens, J. M., Tsui, L. C., and Scherer, S. W. (1996) Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly, Nat. Genet. 14, 353-356.
17. Roessler, E., Du, Y. Z., Mullor, J. L., Casas, E., Allen, W. P., Gillessen-Kaesbach, G., Roeder, E. R., Ming, J. E., Ruiz i Altaba, A., and Muenke, M. (2003) Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features, Proc. Natl. Acad. Sci. U.S.A. 100, 13424-13429.
18. Ming, J. E., Kaupas, M. E., Roessler, E., Brunner, H. G., Golabi, M., Tekin, M., Stratton, R. F., Sujansky, E., Bale, S. J., and Muenke, M. (2002) Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly, Hum. Genet. 110, 297-301.
19. Radhakrishna, U., Wild, A., Grzeschik, K. H., and Antonarakis, S. E. (1997) Mutation in GLI3 in postaxial polydactyly type A, Nat. Genet. 17, 269-271.
20. Xie, J., Murone, M., Luoh, S. M., Ryan, A., Gu, Q., Zhang, C., Bonifas, J. M., Lam, C. W., Hynes, M., Goddard, A., Rosenthal, A., Epstein, E. H., Jr., and de Sauvage, F. J. (1998) Activating Smoothened mutations in sporadic basal-cell carcinoma, Nature 391, 90-92.
21. Johnson, R. L., Rothman, A. L., Xie, J., Goodrich, L. V., Bare, J. W., Bonifas, J. M., Quinn, A. G., Myers, R. M., Cox, D. R., Epstein, E. H., Jr., and Scott, M. P. (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome, Science 272, 1668-1671.
22. Taylor, M. D., Liu, L., Raffel, C., Hui, C. C., Mainprize, T. G., Zhang, X., Agatep, R., Chiappa, S., Gao, L., Lowrance, A., Hao, A., Goldstein, A. M., Stavrou, T., Scherer, S. W., Dura, W. T., Wainwright, B., Squire, J. A., Rutka, J. T., and Hogg, D. (2002) Mutations in SUFU predispose to medulloblastoma, Nat. Genet. 31, 306-310.
23. Berman, D. M., Karhadkar, S. S., Maitra, A., Montes De Oca, R., Gerstenblith, M. R., Briggs, K., Parker, A. R., Shimada, Y., Eshleman, J. R., Watkins, D. N., and Beachy, P. A. (2003) Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours, Nature 425, 846-851.
24. Thayer, S. P., di Magliano, M. P., Heiser, P. W., Nielsen, C. M., Roberts, D. J., Lauwers, G. Y., Qi, Y. P., Gysin, S., Fernández-del Castillo, C., Yajnik, V., Antoniu, B., McMahon, M., Warshaw, A. L., and Hebrok, M. (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis, Nature 425, 851-856.
25. Binns, W., Thacker, E. J., James, L. F., and Huffman, W. T. (1959) A congenital cyclopiantype malformation in lambs, J. Am. Vet. Med. Assoc. 134, 180-183.
26. Chen, J. K., Taipale, J., Cooper, M. K., and Beachy, P. A. (2002) Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened, Genes Dev. 16, 2743-2748.
27. Chen, J. K., Taipale, J., Young, K. E., Maiti, T., and Beachy, P. A. (2002) Small molecule modulation of Smoothened activity, Proc. Natl. Acad. Sci. U.S.A. 99, 14071-14076.
28. Von Hoff, D., Lorusso, P., Rudin, C., Reddy, J., Yauch, R., Tibes, R., Weiss, G., Borad, M., Hann, C., Brahmer, J., Mackey, H., Lum, B., Darbonne, W., Marsters, J., de Sauvage, F., and Low, J. (2009) Inhibition of the Hedgehog pathway in advanced basal-cell carcinoma, N. Engl. J. Med. .
29. Tremblay, M. R., Lescarbeau, A., Grogan, M. J., Tan, E., Lin, G., Austad, B. C., Yu, L. C., Behnke, M. L., Nair, S. J., Hagel, M., White, K., Conley, J., Manna, J. D., Alvarez-Diez, T. M., Hoyt, J., Woodward, C. N., Sydor, J. R., Pink, M., MacDougall, J., Campbell, M. J., Cushing, J., Ferguson, J., Curtis, M. S., McGovern, K., Read, M. A., Palombella, V. J., Adams, J., and Castro, A. C. (2009) Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926), J. Med. Chem. 52, 4400-4418.
30. Miller-Moslin, K., Peukert, S., Jain, R. K., McEwan, M. A., Karki, R., Llamas, L., Yusuff, N., He, F., Li, Y., Sun, Y., Dai, M., Perez, L., Michael, W., Sheng, T., Lei, H., Zhang, R., Williams, J., Bourret, A., Ramamurthy, A., Yuan, J., Guo, R., Matsumoto, M., Vattay, A., Maniara, W., Amaral, A., Dorsch, M., and Kelleher, J. F., 3rd (2009) 1-Amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity, J. Med. Chem. 52, 3954-3968.
31. Frank-Kamenetsky, M., Zhang, X. M., Bottega, S., Guicherit, O., Wichterle, H., Dudek, H., Bumcrot, D., Wang, F. Y., Jones, S., Shulok, J., Rubin, L. L., and Porter, J. A. (2002) Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists, J. Biol. 1, 10.
32. Sinha, S., and Chen, J. K. (2006) Purmorphamine activates the Hedgehog pathway by targeting Smoothened, Nat. Chem. Biol. 2, 29-30.
33. Wu, X., Ding, S., Ding, Q., Gray, N. S., and Schultz, P. G. (2002) A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells, J. Am. Chem. Soc. 124, 14520-14521.
34. Stanton, B. Z., Peng, L. F., Maloof, N., Nakai, K., Wang, X., Duffner, J. L., Taveras, K. M., Hyman, J. M., Lee, S. W., Koehler, A. N., Chen, J. K., Fox, J. L., Mandinova, A., and Schreiber, S. L. (2009) A small molecule that binds Hedgehog and blocks its signaling in human cells, Nat. Chem. Biol. 5, 154-156.
35. Lauth, M., Bergström, A., Shimokawa, T., and Toftgård, R. (2007) Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists, Proc. Natl. Acad. Sci. U.S.A. 104, 8455-8460.
36. Hosoya, T., Arai, M. A., Koyano, T., Kowithayakorn, T., and Ishibashi, M. (2008) Naturally occurring small-molecule inhibitors of hedgehog/GLI-mediated transcription, ChemBioChem 9, 1082-1092.
37. Hyman, J. M., Firestone, A. J., Heine, V. M., Zhao, Y., Ocasio, C. A., Han, K., Sun, M., Rack, P. G., Sinha, S., Wu, J. J., Solow-Cordero, D. E., Jiang, J., Rowitch, D. H., and Chen, J. K. (2009) Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade, Proc. Natl. Acad. Sci. U.S.A. 106, 14132-14137.
38. Bambakidis, N. C., Horn, E. M., Nakaji, P., Theodore, N., Bless, E., Dellovade, T., Ma, C., Wang, X., Preul, M. C., Coons, S. W., Spetzler, R. F., and Sonntag, V. K. (2009) Endogenous stem cell proliferation induced by intravenous hedgehog agonist administration after contusion in the adult rat spinal cord, J. Neurosurg. Spine 10, 171-176.
39. Soundararajan, P., Miles, G. B., Rubin, L. L., Brownstone, R. M., and Rafuse, V. F. (2006) Motoneurons derived from embryonic stem cells express transcription factors and develop phenotypes characteristic of medial motor column neurons, J. Neurosci. 26, 3256-3268.
40. Paladini, R. D., Saleh, J., Qian, C., Xu, G.-X., and Rubin, L. L. (2005) Modulation of hair growth with small molecule agonists of the hedgehog signaling pathway, J. Invest. Dermatol. 125, 638-646.
41. Berman, D. M., Karhadkar, S. S., Hallahan, A. R., Pritchard, J. I., Eberhart, C. G., Watkins, D. N., Chen, J. K., Cooper, M. K., Taipale, J., Olson, J. M., and Beachy, P. A. (2002) Medulloblastoma growth inhibition by hedgehog pathway blockade, Science 297, 1559-1561.
42. Yauch, R. L., Gould, S. E., Scales, S. J., Tang, T., Tian, H., Ahn, C. P., Marshall, D., Fu, L., Januario, T., Kallop, D., Nannini-Pepe, M., Kotkow, K., Marsters, J. C., Rubin, L. L., and de Sauvage, F. J. (2008) A paracrine requirement for hedgehog signalling in cancer, Nature 455, 406-410.
43. Yauch, R., Dijkgraaf, G., Alicke, B., Januario, T., Ahn, C., Holcomb, T., Pujara, K., Stinson, J., Callahan, C., Tang, T., Bazan, J., Kan, Z., Seshagiri, S., Hann, C., Gould, S., Low, J., Rudin, C., and de Sauvage, F. (2009) Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma, Science 326, 572-574.
44. van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A. P., Tjon-Pon-Fong, M., Moerer, P., van den Born, M., Soete, G., Pals, S., Eilers, M., Medema, R., and Clevers, H. (2002) The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells, Cell 111, 241-250.
45. Austin, T. W., Solar, G. P., Ziegler, F. C., Liem, L., and Matthews, W. (1997) A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells, Blood 89, 3624-3635.
46. Dunn, K. J., Williams, B. O., Li, Y., and Pavan, W. J. (2000) Neural crest-directed gene transfer demonstrates Wnt1 role in melanocyte expansion and differentiation during mouse development, Proc. Natl. Acad. Sci. U.S.A. 97, 10050-10055.
47. Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., and Kinzler, K. W. (1992) APC mutations occur early during colorectal tumorigenesis, Nature 359, 235-237.
48. Liu, W., Dong, X., Mai, M., Seelan, R. S., Taniguchi, K., Krishnadath, K. K., Halling, K. C., Cunningham, J. M., Boardman, L. A., Qian, C., Christensen, E., Schmidt, S. S., Roche, P. C., Smith, D. I., and Thibodeau, S. N. (2000) Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signalling, Nat. Genet. 26, 146-147.
49. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. (1997) Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC, Science 275, 1787-1790.
50. Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., Yamaoka, Y., and Nakamura, Y. (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1, Nat. Genet. 24, 245-250.
51. Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., and Polakis, P. (1997) Stabilization of β-catenin by genetic defects in melanoma cell lines, Science 275, 1790-1792.
52. Jiao, X., Ventruto, V., Trese, M. T., Shastry, B. S., and Hejtmancik, J. F. (2004) Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5, Am. J. Hum. Genet. 75, 878-884.
53. Robitaille, J., Macdonald, M. L., Kaykas, A., Sheldahl, L. C., Zeisler, J., Dube, M. P., Zhang, L. H., Singaraja, R. R., Guernsey, D. L., Zheng, B., Siebert, L. F., Hoskin-Mott, A., Trese, M. T., Pimstone, S. N., Shastry, B. S., Moon, R. T., Hayden, M. R., Goldberg, Y. P., and Samuels, M. E. (2002) Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy, Nat. Genet. 32, 326-330.
54. Woods, C. G., Stricker, S., Seemann, P., Stern, R., Cox, J., Sherridan, E., Roberts, E., Springell, K., Scott, S., Karbani, G., Sharif, S. M., Toomes, C., Bond, J., Kumar, D., Al-Gazali, L., and Mundlos, S. (2006) Mutations in WNT7A cause a range of limb malformations, including Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome, Am. J. Hum. Genet. 79, 402-408.
55. Chen, B., Dodge, M. E., Tang, W., Lu, J., Ma, Z., Fan, C.-W., Wei, S., Hao, W., Kilgore, J., Williams, N. S., Roth, M. G., Amatruda, J. F., Chen, C., and Lum, L. (2009) Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer, Nat. Chem. Biol. 5, 100-107.
56. Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., Hild, M., Shi, X., Wilson, C. J., Mickanin, C., Myer, V., Fazal, A., Tomlinson, R., Serluca, F., Shao, W., Cheng, H., Shultz, M., Rau, C., Schirle, M., Schlegl, J., Ghidelli, S., Fawell, S., Lu, C., Curtis, D., Kirschner, M. W., Lengauer, C., Finan, P. M., Tallarico, J. A., Bouwmeester, T., Porter, J. A., Bauer, A., and Cong, F. (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling, Nature 461, 614-620.
57. Meijer, L., Skaltsounis, A. L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, C. A., Brivanlou, A., Dajani, R., Crovace, C., Tarricone, C., Musacchio, A., Roe, S. M., Pearl, L., and Greengard, P. (2003) GSK-3-selective inhibitors derived from Tyrian purple indirubins, Chem. Biol. 10, 1255-1266.
58. Kulkarni, N. H., Onyia, J. E., Zeng, Q., Tian, X., Liu, M., Halladay, D. L., Frolik, C. A., Engler, T., Wei, T., Kriauciunas, A., Martin, T. J., Sato, M., Bryant, H. U., and Ma, Y. L. (2006) Orally bioavailable GSK-3α/β dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo, J. Bone Miner. Res. 21, 910-920.
59. North, T. E., Goessling, W., Walkley, C. R., Lengerke, C., Kopani, K. R., Lord, A. M., Weber, G. J., Bowman, T. V., Jang, I.-H., Grosser, T., Fitzgerald, G. A., Daley, G. Q., Orkin, S. H., and Zon, L. I. (2007) Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis, Nature 447, 1007-1011.
60. Lepourcelet, M., Chen, Y.-N. P., France, D. S., Wang, H., Crews, P., Petersen, F., Bruseo, C., Wood, A. W., and Shivdasani, R. A. (2004) Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex, Cancer Cell 5, 91-102.
61. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., and Brivanlou, A. H. (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor, Nat. Med. 10, 55-63.
62. Castelo-Branco, G., Rawal, N., and Arenas, E. (2004) GSK-3β inhibition/β-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons, J. Cell Sci. 117, 5731-5737.
63. Goessling, W., North, T. E., Loewer, S., Lord, A. M., Lee, S., Stoick-Cooper, C. L., Weidinger, G., Puder, M., Daley, G. Q., Moon, R. T., and Zon, L. I. (2009) Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration, Cell 136, 1136-1147.
64. Sukhdeo, K., Mani, M., Zhang, Y., Dutta, J., Yasui, H., Rooney, M. D., Carrasco, D. E., Zheng, M., He, H., Tai, Y. T., Mitsiades, C., Anderson, K. C., and Carrasco, D. R. (2007) Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma, Proc. Natl. Acad. Sci. U.S.A. 104, 7516-7521.
65. Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kriz, R. W., Hewick, R. M., and Wang, E. A. (1988) Novel regulators of bone formation: molecular clones and activities, Science 242, 1528-1534.
66. Jones, C. M., Kuehn, M. R., Hogan, B. L., Smith, J. C., and Wright, C. V. (1995) Nodal-related signals induce axial mesoderm and dorsalize mesoderm during gastrulation, Development 121, 3651-3662.
67. Howe, J. R., Bair, J. L., Sayed, M. G., Anderson, M. E., Mitros, F. A., Petersen, G. M., Velculescu, V. E., Traverso, G., and Vogelstein, B. (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis, Nat. Genet. 28, 184-187.
68. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., and Vogelstein, B., et al. (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability, Science 268, 1336-1338.
69. Pasche, B., Knobloch, T. J., Bian, Y., Liu, J., Phukan, S., Rosman, D., Kaklamani, V., Baddi, L., Siddiqui, F. S., Frankel, W., Prior, T. W., Schuller, D. E., Agrawal, A., Lang, J., Dolan, M. E., Vokes, E. E., Lane, W. S., Huang, C. C., Caldes, T., Di Cristofano, A., Hampel, H., Nilsson, I., von Heijne, G., Fodde, R., Murty, V. V., de la Chapelle, A., and Weghorst, C. M. (2005) Somatic acquisition and signaling of TGFBR1*6A in cancer, J. Am. Med. Assoc. 294, 1634-1646.
70. Schutte, M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Jr., Meltzer, P. S., Hahn, S. A., and Kern, S. E. (1996) DPC4 gene in various tumor types, Cancer Res. 56, 2527-2530.
71. Faiyaz-Ul-Haque, M., Ahmad, W., Zaidi, S. H., Haque, S., Teebi, A. S., Ahmad, M., Cohn, D. H., and Tsui, L. C. (2002) Mutation in the cartilage-derived morphogenetic protein-1 (CDMP1) gene in a kindred affected with fibular hypoplasia and complex brachydactyly (DuPan syndrome), Clin. Genet. 61, 454-458.
72. Johnson, D. W., Berg, J. N., Baldwin, M. A., Gallione, C. J., Marondel, I., Yoon, S. J., Stenzel, T. T., Speer, M., Pericak-Vance, M. A., Diamond, A., Guttmacher, A. E., Jackson, C. E., Attisano, L., Kucherlapati, R., Porteous, M. E., and Marchuk, D. A. (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2, Nat. Genet. 13, 189-195.
73. Lane, K. B., Machado, R. D., Pauciulo, M. W., Thomson, J. R., Phillips, J. A., 3rd, Loyd, J. E., Nichols, W. C., and Trembath, R. C. (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension, Nat. Genet. 26, 81-84.
74. Dalal, B. I., Keown, P. A., and Greenberg, A. H. (1993) Immunocytochemical localization of secreted transforming growth factor-β 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma, Am. J. Pathol. 143, 381-389.
75. Bruna, A., Darken, R. S., Rojo, F., Ocana, A., Penuelas, S., Arias, A., Paris, R., Tortosa, A., Mora, J., Baselga, J., and Seoane, J. (2007) High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene, Cancer Cell 11, 147-160.
76. Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., and Hill, C. S. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7, Mol. Pharmacol. 62, 65-74.
77. Uhl, M., Aulwurm, S., Wischhusen, J., Weiler, M., Ma, J. Y., Almirez, R., Mangadu, R., Liu, Y.-W., Platten, M., Herrlinger, U., Murphy, A., Wong, D. H., Wick, W., Higgins, L. S., and Weller, M. (2004) SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo, Cancer Res. 64, 7954-7961.
78. Yu, P. B., Hong, C. C., Sachidanandan, C., Babitt, J. L., Deng, D. Y., Hoyng, S. A., Lin, H. Y., Bloch, K. D., and Peterson, R. T. (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism, Nat. Chem. Biol. 4, 33-41.
79. Hao, J., Daleo, M. A., Murphy, C. K., Yu, P. B., Ho, J. N., Hu, J., Peterson, R. T., Hatzopoulos, A. K., and Hong, C. C. (2008) Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells, PLoS ONE 3, e2904.
80. Zhou, L., Nguyen, A. N., Sohal, D., Ying Ma, J., Pahanish, P., Gundabolu, K., Hayman, J., Chubak, A., Mo, Y., Bhagat, T. D., Das, B., Kapoun, A. M., Navas, T. A., Parmar, S., Kambhampati, S., Pellagatti, A., Braunchweig, I., Zhang, Y., Wickrema, A., Medicherla, S., Boultwood, J., Platanias, L. C., Higgins, L. S., List, A. F., Bitzer, M., and Verma, A. (2008) Inhibition of the TGF-β receptor I kinase promotes hematopoiesis in MDS, Blood 112, 3434-3443.
81. Moon, J.-A., Kim, H.-T., Cho, I.-S., Sheen, Y. Y., and Kim, D.-K. (2006) IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy, Kidney Int. 70, 1234-1243.
82. Kimelman, D., and Kirschner, M. (1987) Synergistic induction of mesoderm by FGF and TGF-β and the identification of an mRNA coding for FGF in the early Xenopus embryo, Cell 51, 869-877.
83. Hebert, J. M., Rosenquist, T., Gotz, J., and Martin, G. R. (1994) FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations, Cell 78, 1017-1025.
84. Reardon, W., Winter, R. M., Rutland, P., Pulleyn, L. J., Jones, B. M., and Malcolm, S. (1994) Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome, Nat. Genet. 8, 98-103.
85. Shiang, R., Thompson, L. M., Zhu, Y. Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T., and Wasmuth, J. J. (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia, Cell 78, 335-342.
86. Pitteloud, N., Acierno, J. S., Jr., Meysing, A., Eliseenkova, A. V., Ma, J., Ibrahimi, O. A., Metzger, D. L., Hayes, F. J., Dwyer, A. A., Hughes, V. A., Yialamas, M., Hall, J. E., Grant, E., Mohammadi, M., and Crowley, W. F., Jr. (2006) Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism, Proc. Natl. Acad. Sci. U. S. A. 103, 6281-6286.
87. Chesi, M., Nardini, E., Brents, L. A., Schrock, E., Ried, T., Kuehl, W. M., and Bergsagel, P. L. (1997) Frequent translocation t(4; 14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3, Nat. Genet. 16, 260-264.
88. Cappellen, D., De Oliveira, C., Ricol, D., de Medina, S., Bourdin, J., Sastre-Garau, X., Chopin, D., Thiery, J. P., and Radvanyi, F. (1999) Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas, Nat. Genet. 23, 18-20.
89. Tekin, M., Hismi, B. O., Fitoz, S., Ozdag, H., Cengiz, F. B., Sirmaci, A., Aslan, I., Inceoglu, B., Yuksel-Konuk, E. B., Yilmaz, S. T., Yasun, O., and Akar, N. (2007) Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia, Am. J. Hum. Genet. 80, 338-344.
90. Entesarian, M., Dahlqvist, J., Shashi, V., Stanley, C. S., Falahat, B., Reardon, W., and Dahl, N. (2007) FGF10 missense mutations in aplasia of lacrimal and salivary glands (ALSG), Eur. J. Hum. Genet. 15, 379-382.
91. Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., and Malcolm, S., et al. (1994) A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome, Nat. Genet. 8, 269-274.
92. Dutt, A., Salvesen, H. B., Chen, T. H., Ramos, A. H., Onofrio, R. C., Hatton, C., Nicoletti, R., Winckler, W., Grewal, R., Hanna, M., Wyhs, N., Ziaugra, L., Richter, D. J., Trovik, J., Engelsen, I. B., Stefansson, I. M., Fennell, T., Cibulskis, K., Zody, M. C., Akslen, L. A., Gabriel, S., Wong, K. K., Sellers, W. R., Meyerson, M., and Greulich, H. (2008) Drug-sensitive FGFR2 mutations in endometrial carcinoma, Proc. Natl. Acad. Sci. U.S.A. 105, 8713-8717.
93. Mohammadi, M., McMahon, G., Sun, L., Tang, C., Hirth, P., Yeh, B. K., Hubbard, S. R., and Schlessinger, J. (1997) Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors, Science 276, 955-960.
94. Mohammadi, M., Froum, S., Hamby, J. M., Schroeder, M. C., Panek, R. L., Lu, G. H., Eliseenkova, A. V., Green, D., Schlessinger, J., and Hubbard, S. R. (1998) Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain, EMBO J. 17, 5896-5904.
95. Grand, E. K., Chase, A. J., Heath, C., Rahemtulla, A., and Cross, N. C. (2004) Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074, Leukemia 18, 962-966.
96. Pardo, O. E., Latigo, J., Jeffery, R. E., Nye, E., Poulsom, R., Spencer-Dene, B., Lemoine, N. R., Stamp, G. W., Aboagye, E. O., and Seckl, M. J. (2009) The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo, Cancer Res. 69, 8645-8651.
97. Lyons, J. F., Wilhelm, S., Hibner, B., and Bollag, G. (2001) Discovery of a novel Raf kinase inhibitor, Endocr. Relat. Cancer 8, 219-225.
98. Rinehart, J., Adjei, A. A., Lorusso, P. M., Waterhouse, D., Hecht, J. R., Natale, R. B., Hamid, O., Varterasian, M., Asbury, P., Kaldjian, E. P., Gulyas, S., Mitchell, D. Y., Herrera, R., Sebolt-Leopold, J. S., and Meyer, M. B. (2004) Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer, J. Clin. Oncol. 22, 4456-4462.
99. Molina, G., Vogt, A., Bakan, A., Dai, W., Queiroz de Oliveira, P., Znosko, W., Smithgall, T. E., Bahar, I., Lazo, J. S., Day, B. W., and Tsang, M. (2009) Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages, Nat. Chem. Biol. 5, 680-687.
100. Varnum-Finney, B., Xu, L., Brashem-Stein, C., Nourigat, C., Flowers, D., Bakkour, S., Pear, W. S., and Bernstein, I. D. (2000) Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling, Nat. Med. 6, 1278-1281.
101. Hitoshi, S., Alexson, T., Tropepe, V., Donoviel, D., Elia, A. J., Nye, J. S., Conlon, R. A., Mak, T. W., Bernstein, A., and van der Kooy, D. (2002) Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells, Genes Dev. 16, 846-858.
102. Lanford, P. J., Lan, Y., Jiang, R., Lindsell, C., Weinmaster, G., Gridley, T., and Kelley, M. W. (1999) Notch signalling pathway mediates hair cell development in mammalian cochlea, Nat. Genet. 21, 289-292.
103. Conlon, R. A., Reaume, A. G., and Rossant, J. (1995) Notch1 is required for the coordinate segmentation of somites, Development 121, 1533-1545.
104. Lawson, N. D., Scheer, N., Pham, V. N., Kim, C. H., Chitnis, A. B., Campos-Ortega, J. A., and Weinstein, B. M. (2001) Notch signaling is required for arterial-venous differentiation during embryonic vascular development, Development 128, 3675-3683.
105. McDaniell, R., Warthen, D. M., Sanchez-Lara, P. A., Pai, A., Krantz, I. D., Piccoli, D. A., and Spinner, N. B. (2006) NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway, Am. J. Hum. Genet. 79, 169-173.
106. Li, L., Krantz, I. D., Deng, Y., Genin, A., Banta, A. B., Collins, C. C., Qi, M., Trask, B. J., Kuo, W. L., Cochran, J., Costa, T., Pierpont, M. E., Rand, E. B., Piccoli, D. A., Hood, L., and Spinner, N. B. (1997) Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1, Nat. Genet. 16, 243-251.
107. Oda, T., Elkahloun, A. G., Pike, B. L., Okajima, K., Krantz, I. D., Genin, A., Piccoli, D. A., Meltzer, P. S., Spinner, N. B., Collins, F. S., and Chandrasekharappa, S. C. (1997) Mutations in the human Jagged1 gene are responsible for Alagille syndrome, Nat. Genet. 16, 235-242.
108. Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cecillion, M., Marechal, E., Maciazek, J., Vayssiere, C., Cruaud, C., Cabanis, E. A., Ruchoux, M. M., Weissenbach, J., Bach, J. F., Bousser, M. G., and Tournier-Lasserve, E. (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia, Nature 383, 707-710.
109. Bulman, M. P., Kusumi, K., Frayling, T. M., McKeown, C., Garrett, C., Lander, E. S., Krumlauf, R., Hattersley, A. T., Ellard, S., and Turnpenny, P. D. (2000) Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis, Nat. Genet. 24, 438-441.
110. Reedijk, M., Odorcic, S., Chang, L., Zhang, H., Miller, N., Mc-Cready, D. R., Lockwood, G., and Egan, S. E. (2005) High-level co-expression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival, Cancer Res. 65, 8530-8537.
111. Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P. t., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., and Aster, J. C. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia, Science 306, 269-271.
112. Dovey, H. F., John, V., Anderson, J. P., Chen, L. Z., de Saint Andrieu, P., Fang, L. Y., Freedman, S. B., Folmer, B., Goldbach, E., Holsztynska, E. J., Hu, K. L., Johnson-Wood, K. L., Kennedy, S. L., Kholodenko, D., Knops, J. E., Latimer, L. H., Lee, M., Liao, Z., Lieberburg, I. M., Motter, R. N., Mutter, L. C., Nietz, J., Quinn, K. P., Sacchi, K. L., Seubert, P. A., Shopp, G. M., Thorsett, E. D., Tung, J. S., Wu, J., Yang, S., Yin, C. T., Schenk, D. B., May, P. C., Altstiel, L. D., Bender, M. H., Boggs, L. N., Britton, T. C., Clemens, J. C., Czilli, D. L., Dieckman-McGinty, D. K., Droste, J. J., Fuson, K. S., Gitter, B. D., Hyslop, P. A., Johnstone, E. M., Li, W. Y., Little, S. P., Mabry, T. E., Miller, F. D., and Audia, J. E. (2001) Functional γ-secretase inhibitors reduce β-amyloid peptide levels in brain, J. Neurochem. 76, 173-181.
113. Hayes, S., Nelson, B. R., Buckingham, B., and Reh, T. A. (2007) Notch signaling regulates regeneration in the avian retina, Dev. Biol. 312, 300-311.
114. Yamamoto, N., Tanigaki, K., Tsuji, M., Yabe, D., Ito, J., and Honjo, T. (2006) Inhibition of Notch/RBP-J signaling induces hair cell formation in neonate mouse cochleas, J. Mol. Med. 84, 37-45.
115. Rao, S. S., O'Neil, J., Liberator, C. D., Hardwick, J. S., Dai, X., Zhang, T., Tyminski, E., Yuan, J., Kohl, N. E., Richon, V. M., Van der Ploeg, L. H. T., Carroll, P. M., Draetta, G. F., Look, A. T., Strack, P. R., and Winter, C. G. (2009) Inhibition of NOTCH signaling by γ secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells, Cancer Res. 69, 3060-3068.
116. Tarassishin, L., Yin, Y. I., Bassit, B., and Li, Y.-M. (2004) Processing of Notch and amyloid precursor protein by γ-secretase is spatially distinct, Proc. Natl. Acad. Sci. U.S.A. 101, 17050-17055.
117. Moellering, R. E., Cornejo, M., Davis, T. N., Del Bianco, C., Aster, J. C., Blacklow, S. C., Kung, A. L., Gilliland, D. G., Verdine, G. L., and Bradner, J. E. (2009) Direct inhibition of the NOTCH transcription factor complex, Nature 462, 182-188.
118. Ying, Q. L., Nichols, J., Chambers, I., and Smith, A. (2003) BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3, Cell 115, 281-292.
119. Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J. L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk, M. S., Llanas, R. A., and Thomson, J. A. (2006) Derivation of human embryonic stem cells in defined conditions, Nat. Biotechnol. 24, 185-187.
120. Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., and Smith, A. (2008) The ground state of embryonic stem cell self-renewal, Nature 453, 519-523.
121. Chen, S., Do, J. T., Zhang, Q., Yao, S., Yan, F., Peters, E. C., Schöler, H. R., Schultz, P. G., and Ding, S. (2006) Self-renewal of embryonic stem cells by a small molecule, Proc. Natl. Acad. Sci. U.S.A. 103, 17266-17271.
122. Miyabayashi, T., Yamamoto, M., Sato, A., Sakano, S., and Takahashi, Y. (2008) Indole derivatives sustain embryonic stem cell self-renewal in long-term culture, Biosci. Biotechnol. Biochem. 72, 1242-1248.
123. Borowiak, M., Maehr, R., Chen, S., Chen, A. E., Tang, W., Fox, J. L., Schreiber, S. L., and Melton, D. A. (2009) Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells, Cell Stem Cell 4, 348-358.
124. Chen, S., Borowiak, M., Fox, J. L., Maehr, R., Osafune, K., Davidow, L., Lam, K., Peng, L. F., Schreiber, S. L., Rubin, L. L., and Melton, D. (2009) A small molecule that directs differentiation of human ESCs into the pancreatic lineage, Nat. Chem. Biol. 5, 258-265.
125. Warashina, M., Min, K. H., Kuwabara, T., Huynh, A., Gage, F. H., Schultz, P. G., and Ding, S. (2006) A synthetic small molecule that induces neuronal differentiation of adult hippocampal neural progenitor cells, Angew. Chem., Int. Ed.. 45, 591-593.
126. Sadek, H., Hannack, B., Choe, E., Wang, J., Latif, S., Garry, M. G., Garry, D. J., Longgood, J., Frantz, D. E., Olson, E. N., Hsieh, J., and Schneider, J. W. (2008) Cardiogenic small molecules that enhance myocardial repair by stem cells, Proc. Natl. Acad. Sci. U.S.A. 105, 6063-6068.
127. Takahashi, K., and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell 126, 663-676.
128. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell 131, 861-872.
129. Okita, K., Ichisaka, T., and Yamanaka, S. (2007) Generation of germline-competent induced pluripotent stem cells, Nature 448, 313-317.
130. Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., and Woltjen, K. (2009) Virus-free induction of pluripotency and subsequent excision of reprogramming factors, Nature 458, 771-775.
131. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., and Hochedlinger, K. (2008) Induced pluripotent stem cells generated without viral integration, Science 322, 945-949.
132. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., and Yamanaka, S. (2008) Generation of mouse induced pluripotent stem cells without viral vectors, Science 322, 949-953.
133. Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., and Melton, D. A. (2008) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds, Nat. Biotechnol. 26, 795-797.
134. Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., and Meissner, A. (2008) Dissecting direct reprogramming through integrative genomic analysis, Nature 454, 49-55.
135. Shi, Y., Desponts, C., Do, J. T., Hahm, H. S., Scholer, H. R., and Ding, S. (2008) Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds, Cell Stem Cell 3, 568-574.
136. Lyssiotis, C. A., Foreman, R. K., Staerk, J., Garcia, M., Mathur, D., Markoulaki, S., Hanna, J., Lairson, L. L., Charette, B. D., Bouchez, L. C., Bollong, M., Kunick, C., Brinker, A., Cho, C. Y., Schultz, P. G., and Jaenisch, R. (2009) Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4, Proc. Natl. Acad. Sci. U.S.A. 106, 8912-8917.
137. Maherali, N., and Hochedlinger, K. (2009) TGF-β signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc, Curr. Biol. 19, 1718-1723.
138. Lin, T., Ambasudhan, R., Yuan, X., Li, W., Hilcove, S., Abujarour, R., Lin, X., Hahm, H. S., Hao, E., Hayek, A., and Ding, S. (2009) A chemical platform for improved induction of human iPSCs, Nat. Methods 6, 805-808.